haemodialysis patients. End-stage renal disease
Conditions
Interventions
Treatment - Drugs
Placebo
Sponsors
Isfahan university of medical sciences
Eligibility
Sex/Gender
All
Age
21 Years to 100 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age upper than 21, have history of haemodialysis at least for one month before, having informed consent, no history of carnitine use in previous 8 weeks, no history of infectious disease or fever in previous month. Exclusion criteria: having side effects after taking tablets (like hypertension, dizziness, blurred vision, minimental status and diarrhea), person who want to exit from the staudy,having an infectious problem or antibiotic usage or if a patient change the dialysis method, migrate from the center, having renal transplantation .
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Albomin of plasma. Timepoint: 1 month. Method of measurement: Bromocrosol Green method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: evrey month. Method of measurement: questionnair.;Hemoglobin. Timepoint: every month. Method of measurement: automated analyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfrooz Eshaghian
Isfahan university of medical scieces
Outcome results
None listed